Home > News > It-baby with growing pains gets another EUR 3 million
July 12th, 2007
It-baby with growing pains gets another EUR 3 million
Abstract:
Eight year old Capres, an IT-company from the entrepreneurial environment at the Technical University of Denmark, is far behind the beginner stage and investors are now injecting EUR 3 million in the small nanotechnology company.
The IT-company Capres, which is a spin-out from the entrepreneurial environment at DTU, is far behind the beginner stage and after having presented a multiplied surplus investors are now injecting another EUR 3 million in the small nanotechnology company. The capital injection is to alleviate the growing pains and help to get a new product within the semiconductor generation out on the market to the chip producers', writes the Danish business daily Børsen.
Source:
copcap.com
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Chip Technology
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||